Canakinumab Subcutaneous and Indomethacin Extended-Release Capsules
Determining the interaction of Canakinumab Subcutaneous and Indomethacin Extended-Release Capsules and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: canakinumab
Brand name: Ilaris
Synonyms: Canakinumab
Generic Name: indomethacin
Brand name: Indocin, Indocin SR, Tivorbex
Synonyms: Indomethacin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Canakinumab Subcutaneous-Indomethacin Injection
- Canakinumab Subcutaneous-Indomethacin Intravenous
- Canakinumab Subcutaneous-Indomethacin Rectal
- Canakinumab Subcutaneous-Indomethacin Suppositories
- Canakinumab Subcutaneous-Indomethacin Suppository
- Canakinumab Subcutaneous-Indomethacin Suspension
- Indomethacin Extended-Release Capsules-Canasa
- Indomethacin Extended-Release Capsules-Canasa Pac rectal
- Indomethacin Extended-Release Capsules-Canasa rectal
- Indomethacin Extended-Release Capsules-Cancidas
- Indomethacin Extended-Release Capsules-Candesartan
- Indomethacin Extended-Release Capsules-Candesartan and Hydrochlorothiazide